Before You Expand, Read This: The Strategy Most Startups Overlook
Why Market Penetration Could Be the Smartest—and Fastest—Way to Grow in Health Tech
Dear Readers,
Welcome to the latest edition of the HealthVC newsletter. Today, we’re diving into a core concept that is often overshadowed by flashier strategies: Market Penetration. For founders and operators navigating the health tech and life sciences landscape—especially in fragmented, highly regulated European markets—this strategy offers an underappreciated but powerful lever for growth. In this edition, we’ll unpack what market penetration really means, why it’s especially relevant to capital-efficient startups, how to apply it thoughtfully, and where its limitations lie. If you’ve been tempted to expand your product line or chase new markets, this is your invitation to pause and ask: Have you truly maximized what you already have? Let’s dig in.
Understanding Market Penetration
At its most basic, market penetration refers to the effort of increasing sales of an existing product or service within its current market. It’s about getting more people in your existing target audience to adopt your offering, and getting your current users to use it more often or more deeply. This can involve taking market share from competitors, convincing non-users to finally convert, or expanding usage behavior among those who already buy from you.
But beyond the textbook definition, market penetration is about depth over breadth. It’s the discipline of doing more with what you already know—your product, your buyer personas, your channels, and your market’s behavior. It’s one of the few growth strategies that doesn’t demand more complexity, but rather more focus. And for startups operating in capital-intensive or compliance-heavy sectors like digital health or diagnostics, that focus is often your most defensible asset.
Market penetration isn’t just about pushing harder. It’s about listening better. It asks: Have you truly reached all your potential customers? Are your current users using your product to its full potential? Are you as embedded as possible in their daily workflow or behavior?
If the answer is no, your next growth move may not require a pivot—it may require refinement.
Why Market Penetration Is So Effective in Health Tech
In the health tech and life sciences sectors, especially in Europe, expansion is rarely easy. New markets often mean new languages, different reimbursement codes, unfamiliar regulators, and entirely different systems of care. That’s why market penetration can be a uniquely powerful strategy in this space—it leverages familiarity and mitigates risk.
Focusing on market penetration enables startups to grow without the drag of additional complexity. You’re not dealing with a new buyer journey, new legal reviews, or new distribution partnerships. You’re iterating inside a known system. This makes it easier to forecast, budget, and optimize.
Moreover, the buyer relationships you’ve already built—whether with hospitals, insurers, clinics, or patients—are often stickier than in other sectors. Trust is hard-earned in health, and once you have it, it’s your responsibility to deepen it. Penetrating that existing trust base is not only more efficient, but more likely to lead to long-term defensibility.
There’s also an advantage when it comes to outcomes. Health tech products are rarely bought purely for convenience—they’re sold on evidence, outcomes, and integration. When you penetrate a market more deeply, you gather more outcome data, better understand how your product works in real-world settings, and can use those learnings to optimize both delivery and results.
How to Execute Market Penetration Strategically
Market penetration strategies can take many forms, but all share a common mindset: eliminate friction, deepen value, and expand usage.
Start by assessing untapped potential in your existing market. Are there user segments you’re underserving? Are your competitors vulnerable in particular regions or verticals? Is there underutilization within your current accounts? Many startups think they’ve “won” a customer once the contract is signed, but real market penetration begins after the sale, with education, onboarding, integration, and upsell.
One of the most effective (and underused) approaches is improving usability. Streamlining workflows, simplifying interfaces, and providing better documentation or training materials can all increase daily use, which in turn raises switching costs and improves retention.
Another powerful tactic is building partnerships within your ecosystem—think electronic health record vendors, pharmacy systems, or medical device companies that can accelerate your product’s reach without changing your core audience.
Then there’s pricing and packaging. You might lower barriers to entry through tiered plans, pilot programs, or usage-based pricing. Alternatively, loyalty programs or data access incentives can keep customers engaged while collecting valuable usage insights. But the key is always the same: make it easier to adopt, and harder to leave.
Lastly, communications matter. Repositioning your product within a known audience—through new clinical use cases, targeted thought leadership, or practitioner testimonials—can drive new waves of adoption within your market, without needing to venture into unfamiliar territory.
When Market Penetration Isn’t Enough
No strategy is infinite in its utility. Market penetration eventually runs into natural limits, and recognizing those limits is part of being a disciplined operator.
The most obvious limitation is market saturation. If everyone who could reasonably use your product already is, you’re left with limited growth potential. This is especially true in niche sub-specialties of healthcare where total addressable markets are small and well-defined.
Then there’s competitive pressure. As your market penetration strategy becomes more visible, incumbents or new entrants may mimic your pricing, feature set, or messaging. This can lead to commoditization and margin erosion. In that environment, the company with the strongest customer experience and stickiest product usually wins—but only up to a point.
Finally, a narrow focus on market penetration can create tunnel vision. If your entire strategy revolves around squeezing more out of your current users, you may miss emerging trends, shifting customer needs, or adjacent market opportunities. Staying relevant over the long term requires occasional zooming out—even while executing deeply in the short term.
Case Study: Apple and the iPhone
Let’s take a cue from outside health tech. Apple’s iPhone is often cited as a product of constant innovation, but in reality, much of their success stems from relentless market penetration. Apple routinely releases new models, but their real focus is on getting more people to use the current ones—through pricing tiers, trade-in options, interest-free financing, and ecosystem lock-in via services like iCloud, Apple Health, and the App Store.
Rather than chasing radically different markets, Apple deepens its hold on existing ones. The result? Higher revenue per user, lower churn, and a brand that feels indispensable.
There’s a lesson here for health tech companies: domination doesn’t always require diversification. Sometimes it just requires focus, consistency, and patient execution.
Final Thoughts: Go Deeper Before You Go Wider
In a landscape obsessed with expansion, market penetration reminds us of the value of depth. Especially in health tech, where complexity is the default, growing within the confines of what you already know isn’t playing it safe. It’s playing it smart.
Founders who can demonstrate strong market penetration are often better prepared for the next phase of growth. They’ve earned customer trust. They’ve validated outcomes. They’ve refined operations. And when they do decide to expand, they bring discipline, not just ambition.
So, before you add that next feature or open that new market, ask yourself: have we truly earned the right to expand? Or is there still more value to unlock where we already are?
P.S. Get Early Access to HealthVC Pro
What started as a newsletter breaking down how venture works in Europe…
…has grown into a tactical operating system for:
Founders raising capital across any industry
GPs refining their internal workflows and LP communications
LPs backing new managers or exploring the venture ecosystem
👉 Introducing HealthVC Pro and Pro+ — Upgrade now
Inside, you’ll get access to:
A curated, filterable investor database with 6,000+ entries — updated monthly
Cold outreach templates that actually get replies
Fundraising frameworks, pitch deck examples, and real-world LP materials
Monthly tactical Q&A sessions covering capital calls, investor updates, and more
And for Pro+ members: async feedback on your pitch, outreach strategy, and LP comms
This isn’t theory. It’s fund mechanics and execution, from someone actively raising and deploying capital in Europe.
💬 Join the HealthVC WhatsApp & Substack communities — where founders, GPs, and LPs trade insights, deal flow, and lessons from the front lines.
Don’t forget to check out the HealthVC on YouTube and The Terminology of Venture Capital on Amazon.
Until next time, keep venturing forward!
Now let’s take a look at the latest funding rounds, and M&A deals as well as the latest articles and videos worth reading and watching.